HSCT for MS and Other Autoimmune Diseases
Hematopoietic Stem Cell Transplantation reboots the immune system and has proven to halt the disease progression.
HSCT treatment aims to stop the immune system from damaging myelin, to allow the nervous system to restore. The treatment includes high-dose chemotherapy, followed by autologous stem cell transplantation.

Get to know us
The people who make this possible

Jacob M. Rowe
M.D., Ph.D., D.Sci.
Chief, Department of Hematology and Bone Marrow Transplantation, Shaarei Zedek Medical Center

Igor B. Resnick
M.D., Ph.D., D.Sci.
Director of the Program For Haematology, Immunology, BMT and Cell Therapy, St. Marina Hospital
Ariel Miller
M.D., Ph.D., D.Sci.
Chief, Center for Multiple
Sclerosis and Brain Research, Carmel Medical Center

Yana Karaly &
Irina Resnick
Founders of HSCT for MS programs in Israel and Bulgaria

Contact Us
Please do not hesitate to contact us with any questions you have.
We'll be happy to help.